Qvt Financial LP Aadi Bioscience, Inc. Put Options Transaction History
Qvt Financial LP
- $1.02 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AADI
# of Institutions
57Shares Held
15.6MCall Options Held
15KPut Options Held
3.1K-
Avoro Capital Advisors LLC New York, NY2.85MShares$7.69 Million0.13% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.1MShares$5.67 Million4.12% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$4.99 Million8.31% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.15MShares$3.1 Million1.96% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY818KShares$2.21 Million2.93% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $56.7M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...